Molecular and clinical characteristics of hepatitis B virus in Korea

Journal of Medical Virology

Volumn 82, Issue 7, 2010, Pages 1126-1134

  Ahn, Sang Hoon ^a,b,c   Yuen, Lilly ^b   Han, Kwang Hyub ^a,c   Littlejohn, Margaret ^b   Chang, Hye Young ^a,c   Damerow, Hans ^b   Ayres, Anna ^b   Heo, Jeong ^c,d   Locarnini, Stephen ^b   Revill, Peter A ^b  

^a Yonsei University College of Medicine   (South Korea)

^b VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^c Liver Cirrhosis Clinical Research Centre   (South Korea)

^d Pusan National University School of Medicine   (South Korea)

Author keywords

Complete genome; Disease progression; Genotype; Hepatitis B virus; Korea; Phylogeny

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

AMINO ACID SUBSTITUTION; ARTICLE; DISEASE COURSE; DISEASE SEVERITY; GENE MUTATION; GENE SEQUENCE; GENETIC RECOMBINATION; GENETIC VARIABILITY; HEPATITIS B; HEPATITIS B VIRUS; KOREA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; NUCLEOTIDE SEQUENCE; AGED; CLASSIFICATION; FEMALE; GENETICS; HUMAN; LIVER TUMOR; MALE; MIDDLE AGED; MOLECULAR GENETICS; PATHOLOGY; PHYLOGENY; SOUTH KOREA; VIROLOGY; VIRUS GENOME; YOUNG ADULT;

HEPATITIS B VIRUS;

AGED; AMINO ACID SUBSTITUTION; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; FEMALE; GENOME, VIRAL; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHYLOGENY; REPUBLIC OF KOREA; YOUNG ADULT;

EID: 77954397663     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21844     Document Type: Article

References (56)

1. Ahn SH, Han KH, Park JY, Lee CK, Kang SW, Chon CY, Kim YS, Park K, Kim DK, Moon YM. 2000. Association between hepatitis B virus infection and HLA-DR type in Korea. Hepatology 31:1371-1373.
2. Ahn SH, Yuen L, Revill P. 2009. Clarification required for the definition of hepatitis B virus subgenotypes C1 and C2. Intervirology 52:321-322.
3. Bertoletti A, Southwood S, Chesnut R, Sette A, Falco M, Ferrara GB, Penna A, Boni C, Fiaccadori F, Ferrari C. 1997. Molecular features of the hepatitis B virus nucleocapsid T-cell epitope 18-27: Interaction with HLA and T-cell receptor. Hepatology 26:1027-1034.
4. Chan HL, Wong ML, Hui AY, Hung LC, Chan FK, Sung JJ. 2003. Hepatitis B virus genotype C takes a more aggressive disease course than hepatitis B virus genotype B in hepatitis B e antigen-positive patients. J Clin Microbiol 41:1277-1279.
5. Chan HL, Hui AY, Wong ML, Tse AM, Hung LC, Wong VW, Sung JJ. 2004. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma. Gut 53:1494-1498. (Pubitemid 39265273)
6. Chen BF, Liu CJ, Jow GM, Chen PJ, Kao JH, Chen DS. 2006. High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. Gastroenterology 130: 1153-1168.
7. Chen CH, Hung CH, Lee CM, Hu TH, Wang JH, Wang JC, Lu SN, Changchien CS. 2007. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients. Gastroenterology 133:1466-1474.
8. Chen CH, Changchien CS, Lee CM, Hung CH, Hu TH, Wang JH, Wang JC, Lu SN. 2008. Combined mutations in pre-s/surface and core promoter/precore regions of hepatitis B virus increase the risk of hepatocellular carcinoma: A case-control study. J Infect Dis 198: 1634-1642.
9. Cho SW, Shin YJ, Hahm KB, Jin JH, Kim YS, Kim JH, Kim HJ. 1999. Analysis of the precore and core promoter DNA sequence in liver tissues from patients with hepatocellular carcinoma. J Korean Med Sci 14:424-430.
10. Choi MS, Kim DY, Lee DH, Lee JH, Koh KC, Paik SW, Rhee JC, Yoo BC. 2007. Clinical significance of pre-S mutations in patients with genotype C hepatitis B virus infection. J Virol Hepat 14:161-168. (Pubitemid 46257181)
11. Choi JW, Ahn SH, Park JY, Chang HY, Kim JK, Baatarkhuu O, Kim do Y, Han KH, Chon CY. 2009. Hepatitis B e antigen-negative mutations in the precore and core promoter regions in Korean patients. J Med Virol 81:594-601.
12. Chu CJ, Hussain M, Lok AS. 2002. Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. Gastroenterology 122:1756-1762. (Pubitemid 34651418)
13. Desmond CP, Bartholomeusz A, Gaudieri S, Revill PA, Lewin SR. 2008. A systematic review of T-cell epitopes in hepatitis B virus: Identification, genotypic variation and relevance to antiviral therapeutics. Antivir Ther 13:161-175. (Pubitemid 351535368)
14. Fan YF, Lu CC, Chen WC, Yao WJ, Wang HC, Chang TT, Lei HY, Shiau AL, Su IJ. 2001. Prevalence and significance of hepatitis B virus (HBV) pre-S mutants in serum and liver at different replicative stages of chronic HBV infection. Hepatology 33:277-286.
15. Fang ZL, Ling R, Wang SS, Nong J, Huang CS, Harrison TJ. 1998. HBV core promoter mutations prevail in patients with hepatocellular carcinoma from Guangxi, China. J Med Virol 56:18-24. (Pubitemid 28380425)
16. Ferrari C, Cavalli A, Penna A, Valli A, Bertoletti A, Pedretti G, Pilli M, Vitali P, Neri TM, Giuberti T, Fiaccadori. 1992. Fine specificity of the human T-cell response to the hepatitis B virus preS1 antigen. Gastroenterology 103:255-263.
17. Gunther S, Li BC, Miska S, Kruger DH, Meisel H, Will H. 1995. A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol 69:5437-5444.
18. Hall T. 1999. Bio Edit: A user friendly biological sequence alignment editor and analysis program for Windows 95/98/NT/. Nucelic Acids Symp 41:95-98.
19. Hsieh YH, Su IJ, Wang HC, Chang WW, Lei HY, Lai MD, Chang WT, Huang W. 2004. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis 25:2023-2032. (Pubitemid 39405923)
20. Huy TT, Ushijima H, Quang VX, Win KM, Luengrojanakul P, Kikuchi K, Sata T, Abe K. 2004. Genotype C of hepatitis B virus can be classified into at least two subgroups. J Gen Virol 85:283-292. (Pubitemid 38262563)
21. Kao JH, Chen PJ, Lai MY, Chen DS. 2000. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology 118:554-559. (Pubitemid 30140853)
22. Kao JH, Chen PJ, Lai MY, Chen DS. 2003. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. Gastroenterology 124:327-334. (Pubitemid 36169249)
23. Kim H, Jee YM, Song BC, Hyun JW, Mun HS, Kim HJ, Oh EJ, Yoon JH, Kim YJ, Lee HS, Hwang ES, Cha CY, Kook YH, Kim BJ. 2007. Analysis of hepatitis B virus quasispecies distribution in a Korean chronic patient based on the full genome sequences. J Med Virol 79:212-219.
24. Kim JK, Chang HY, Lee JM, Baatarkhuu O, Yoon YJ, Park JY, Kim do Y, Han KH, Chon CY, Ahn SH. 2009. Specific mutations in the enhancer II/core promoter/precore regions of hepatitis B virus subgenotype C2 in Korean patients with hepatocellular carcinoma. J Med Virol 81:1002-1008.
25. Kramvis A, Arakawa K, Yu MC, Nogueira R, Stram DO, Kew MC. 2008. Relationship of serological subtype, basic core promoter and precore mutations to genotypes/subgenotypes of hepatitis B virus. J Med Virol 80:27-46.
26. Kuroki K, Floreani M, Mimms LT, Ganem D. 1990. Epitope mapping of the PreS1 domain of the hepatitis B virus large surface protein. Virology 176:620-624.
27. Lee DH, Kim JH, Nam JJ, Kim HR, Shin HR. 2002. Epidemiological findings of hepatitis B infection based on 1998 National Health and Nutrition Survey in Korea. J Korean Med Sci 17:457-462.
28. Lee JM, Ahn SH, Chang HY, Shin JE, Kim DY, Sim MK, Hong SP, Chung HJ, Kim SO, Han KH, Chon CY, Moon YM. 2004. Reappraisal of HBV genotypes and clinical significance in Koreans using MALDI-TOF mass spectrometry. Korean J Hepatol 10:260-270.
29. Lee YS, Suh DJ, Lim YS, Jung SW, Kim KM, Lee HC, Chung YH, Yoo W, Kim SO. 2006. Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy. Hepatology 43:1385-1391. (Pubitemid 43980117)
30. Liu CJ, Kao JH. 2008. Genetic variability of hepatitis B virus and response to antiviral therapy. Antivir Ther 13:613-624.
31. Liu S, Zhang H, Gu C, Yin J, He Y, Xie J, Cao G. 2009. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: A meta-analysis. J Natl Cancer Inst 101:1066-1082.
32. Livingston SE, Simonetti JP, McMahon BJ, Bulkow LR, Hurlburt KJ, Homan CE, Snowball MM, Cagle HH, Williams JL, Chulanov VP. 2007. Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: Preponderance of genotype F. J Infect Dis 195:5-11.
33. Lok AS, Akarca U, Greene S. 1994. Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal. Proc Natl Acad Sci USA 91:4077-4081.
34. Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS, Novak NG, Ingersoll R, Sheppard HW, Ray SC. 1999. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 73:152-160.
35. Mayerat C, Mantegani A, Frei PC. 1999. Does hepatitis B virus (HBV) genotype influence the clinical outcome of HBV infection? J Viral Hepat 6:299-304.
36. Mun HS, Lee SA, Jee Y, Kim H, Park JH, Song BC, Yoon JH, Kim YJ, Lee HS, Hyun JW, Hwang ES, Kook YH, Kim BJ. 2008. The prevalence of hepatitis B virus preS deletions occurring naturally in Korean patients infected chronically with genotype C. J Med Virol 80:1189-1194. (Pubitemid 351705997)
37. Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, Robertson BH, Locarnini S, Magnius LO. 2004. Genetic diversity of hepatitis B virus strains derived worldwide: Genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47: 289-309. (Pubitemid 39541275)
38. Okamoto H, Tsuda F, Akahane Y, Sugai Y, Yoshiba M, Moriyama K, Tanaka T, Miyakawa Y, Mayumi M. 1994. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J Virol 68:8102-8110. (Pubitemid 24984172)
39. Orito E, Ichida T, Sakugawa H, Sata M, Horiike N, Hino K, Okita K, Okanoue T, Iino S, Tanaka E, Suzuki K, Watanabe H, Hige S, Mizokami M. 2001. Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology 34:590-594.
40. Park JH, Cho EW, Lee YJ, Shin SY, Kim KL. 2000. Determination of the protective effects of neutralizing anti-hepatitis B virus (HBV) immunoglobulins by epitope mapping with recombinant HBV surface-antigen proteins. Microbiol Immunol 44:703-710.
41. Revill PA, Littlejohn M, Ayres A, Yuen L, Colledge D, Bartholomeusz A, Sasaduesz J, Lewin SR, Dore GJ, Matthews GV, Thio CL, Locarnini SA. 2007. Identification of a novel hepatitis B virus precore/core deletion mutant in HIV/hepatitis B virus co-infected individuals. Aids 21:1701-1710.
42. Sakamoto T, Tanaka Y, Orito E, Co J, Clavio J, Sugauchi F, Ito K, Ozasa A, Quino A, Ueda R, Sollano J, Mizokami M. 2006. Novel subtypes (subgenotypes) of hepatitis B virus genotypes B and C among chronic liver disease patients in the Philippines. J Gen Virol 87: 1873-1882.
43. Schaefer S, Magnius L, Norder H. 2009. Under construction: Classification of hepatitis B virus genotypes and subgenotypes. Intervirology 52:323-325.
44. Song BC, Suh DJ, Lee HC, Chung YH, Lee YS. 2000. Hepatitis B e antigen seroconversion after lamivudine therapy is not durable in patients with chronic hepatitis B in Korea. Hepatology 32:803-806.
45. Song BC, Cui XJ, Kim H. 2005a. Hepatitis B virus genotypes in Korea: An endemic area of hepatitis B virus infection. Intervirology 48: 133-137.
46. Song BC, Kim H, Kim SH, Cha CY, Kook YH, Kim BJ. 2005b. Comparison of full length sequences of hepatitis B virus isolates in hepatocellular carcinoma patients and asymptomatic carriers of Korea. J Med Virol 75:13-19.
47. Stuyver LJ, Locarnini SA, Lok A, Richman DD, Carman WF, Dienstag JL, Schinazi RF. 2001. Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region. Hepatology 33:751-757.
48. Sugauchi F, Orito E, Ichida T, Kato H, Sakugawa H, Kakumu S, Ishida T, Chutaputti A, Lai CL, Ueda R, Miyakawa Y, Mizokami M. 2002. Hepatitis B virus of genotype B with or without recombination with genotype C over the precore region plus the core gene. J Virol 76: 5985-5992.
49. Sung JJ, Tsui SK, Tse CH, Ng EY, Leung KS, Lee KH, Mok TS, Bartholomeusz A, Au TC, Tsoi KK, Locarnini S, Chan HL. 2008. Genotype-specific genomic markers associated with primary hepatomas, based on complete genomic sequencing of hepatitis B virus. J Virol 82:3604-3611.
50. Tai PC, Suk FM, Gerlich WH, Neurath AR, Shih C. 2002. Hypermodification and immune escape of an internally deleted middle-envelope (M) protein of frequent and predominant hepatitis B virus variants. Virology 292:44-58. (Pubitemid 34925837)
51. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. 1997. The CLUSTAL-X windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25:4876-4882. (Pubitemid 28022245)
52. Wiegand J, Hasenclever D, Tillmann HL. 2008. Should treatment of hepatitis B depend on hepatitis B virus genotypes? A hypothesis generated from an explorative analysis of published evidence. Antivir Ther 13:211-220. (Pubitemid 351535372)
53. Yang HI, Yeh SH, Chen PJ, Iloeje UH, Jen CL, Su J, Wang LY, Lu SN, You SL, Chen DS, Liaw YF, Chen CJ. 2008. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl Cancer Inst 100:1134-1143.
54. Yuen LK, Ayres A, Littlejohn M, Colledge D, Edgely A, Maskill WJ, Locarnini SA, Bartholomeusz A. 2007. SeqHepB: A sequence analysis program and relational database system for chronic hepatitis B. Antiviral Res 75:64-74. (Pubitemid 46621069)
55. Zeng G, Wang Z, Wen S, Jiang J, Wang L, Cheng J, Tan D, Xiao F, Ma S, Li W, Luo K, Naoumov NV, Hou J. 2005. Geographic distribution, virologic and clinical characteristics of hepatitis B virus genotypes in China. J Viral Hepat 12:609-617.
56. Zhong S, Chan JY, Yeo W, Tam JS, Johnson PJ. 2000. Frequent integration of precore/core mutants of hepatitis B virus in human hepatocellular carcinoma tissues. J Viral Hepat 7:115-123. (Pubitemid 30177101)